Entity Common Stock, Shares Outstanding of Ovid Therapeutics Inc. from 13 Jun 2017 to 07 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Ovid Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 13 Jun 2017 to 07 Nov 2025.
  • Ovid Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 07 Nov 2025 was 71,212,353, a 0.28% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Ovid Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 71,212,353 +202,487 +0.28% 07 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 71,109,514 +137,937 +0.19% 08 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 71,109,514 +399,657 +0.56% 07 Mar 2025 10-K/A 30 Apr 2025 2024 FY
Q3 2024 71,009,866 +329,315 +0.47% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 70,971,577 +368,784 +0.52% 10 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 70,709,857 +218,347 +0.31% 05 Mar 2024 10-K 08 Mar 2024 2023 FY
Q3 2023 70,680,551 +213,666 +0.3% 31 Oct 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 70,602,793 +183,405 +0.26% 01 Aug 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 70,491,510 +118,348 +0.17% 10 Mar 2023 10-K 13 Mar 2023 2022 FY
Q3 2022 70,466,885 +2,374,700 +3.5% 04 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 70,419,388 +2,487,392 +3.7% 05 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 70,373,162 +4,619,592 +7% 10 Mar 2022 10-K 15 Mar 2022 2021 FY
Q3 2021 68,092,185 +4,656,963 +7.3% 08 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 67,931,996 +10,848,959 +19% 06 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 65,753,570 +11,043,248 +20% 08 Mar 2021 10-K 15 Mar 2021 2020 FY
Q3 2020 63,435,222 +15,618,788 +33% 05 Nov 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 57,083,037 +18,390,019 +48% 03 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 54,710,322 +16,017,304 +41% 04 Mar 2020 10-K 11 Mar 2020 2019 FY
Q3 2019 47,816,434 +23,162,320 +94% 06 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 38,693,018 +14,061,039 +57% 30 Jul 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 38,693,018 +14,075,039 +57% 29 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 24,654,114 +50,823 +0.21% 01 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 24,631,979 +30,043 +0.12% 02 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 24,617,979 22 Mar 2018 10-K 29 Mar 2018 2017 FY
Q3 2017 24,603,291 08 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 24,601,936 13 Jun 2017 10-Q 13 Jun 2017 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.